Palisade Bio (PALI) Interest Coverage Ratio Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 79.36% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 29.25% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -16.86% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 40.09% |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -57.28% |
| Sep 30, 2025 | 19.09% |
| Jun 30, 2025 | -25.78% |
| Mar 31, 2025 | 15.93% |
| Dec 31, 2024 | -11.86% |
| Sep 30, 2024 | -72.83% |
| Jun 30, 2024 | -247.52% |
| Mar 31, 2024 | -1,376.10% |
| Dec 31, 2023 | -262.48% |
| Sep 30, 2023 | -93.82% |
| Jun 30, 2023 | -76.55% |
| Dec 31, 2022 | -39.19% |
| Sep 30, 2022 | 0.21% |
| Jun 30, 2022 | 42.63% |
| Mar 31, 2022 | -47.24% |
| Dec 31, 2021 | -16.11% |
| Sep 30, 2021 | 56.30% |
| Jun 30, 2021 | 73.25% |
| Mar 31, 2021 | 90.23% |
| Dec 31, 2020 | 71.35% |
| Sep 30, 2020 | 67.40% |
| Jun 30, 2020 | 6.59% |
| Mar 31, 2020 | -193.57% |
| Dec 31, 2019 | -152.79% |
| Sep 30, 2019 | -278.68% |
| Jun 30, 2019 | -582.68% |
| Mar 31, 2019 | -322.68% |
| Dec 31, 2018 | -273.08% |
| Sep 30, 2018 | -398.89% |
| Jun 30, 2018 | -522.18% |
| Mar 31, 2018 | -393.70% |
| Dec 31, 2017 | -302.17% |
| Sep 30, 2017 | -448.22% |
| Jun 30, 2017 | -212.00% |
| Mar 31, 2017 | -36.62% |
| Dec 31, 2016 | -69.62% |
| Sep 30, 2016 | -36.19% |
| Jun 30, 2016 | -17.31% |
| Mar 31, 2016 | 35.44% |
| Dec 31, 2015 | 85.10% |
| Sep 30, 2015 | 88.68% |
| Jun 30, 2015 | 86.00% |
| Mar 31, 2015 | 84.79% |
| Dec 31, 2014 | 84.86% |
| Dec 31, 2013 | -74.69% |
| Sep 30, 2013 | 90.14% |
| Jun 30, 2013 | 86.31% |